Search for: "Janssen Pharmaceutica, Inc." Results 1 - 20 of 57
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2008, 8:28 am
(Apotex) appeals the order of the United States District Court for the District of New Jersey dismissing its declaratory judgment action for noninfringement against Plaintiffs-Appellees Janssen Pharmaceutica, N.V. and Janssen, L.P. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
2 May 2011, 4:30 am by Laura Simons
A Spartanburg, South Carolina judge is set to decide how much money Janssen Pharmaceutica, Inc., a Johnson & Johnson subsidiary, should pay the state for what the jury found to be deceptive marketing by the company of its antipsychotic drug Risperdal. [read post]
18 Aug 2008, 3:48 am
Janssen Pharmaceutica N.V. et al. v. [read post]
11 Nov 2008, 1:00 pm
Janssen Pharmaceutica Products and Alza, the subsidiaries, were responsible for the woman's death. [read post]
13 Jun 2011, 4:30 am by Laura Simons
Earlier this month, the State of South Carolina was awarded $327 million in damages from drugmaker Janssen Pharmaceutica, Inc., a Johnson & Johnson subsidiary, under the state’s Unfair Trade Practices Act for deceptive marketing of its anti-psychotic drug, Risperdal. [read post]
26 Mar 2013, 7:17 am by Brian A. Comer
South Carolina Lawyers Weekly ran an article last week concerning Janssen Pharmaceutica's appeal of a $327 million penalty handed down by Judge Robert Couch in 2011. [read post]
7 Nov 2013, 11:24 pm by Jon Gelman
”Add caption Starr, a former sales representative for Janssen Pharmaceutica, a wholly-owned subsidiary of drugmaker Johnson & Johnson, felt as if she was being encouraged and pressured to market Risperdal off-label. [read post]
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
The court granted Teva’s motion, finding the facts analogous to the Federal Circuit’s decision in Janssen Pharmaceutica, N.V. v. [read post]
2 Sep 2020, 1:45 pm by Tom Lamb
The Defendants named in a typical lawsuit filed on behalf of an Elmiron user who developed vision problems might be some combination of the following: JANSSEN PHARMACEUTICALS, INC., f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutica Inc. [read post]